甲状腺髓样癌合并乳头状癌1例并文献复习

doi:10.3969/j.issn.2095-378X.2022.04.011

外科研究与新技术 ›› 2022, Vol. 11 ›› Issue (4): 270-273.doi: 10.3969/j.issn.2095-378X.2022.04.011

甲状腺髓样癌合并乳头状癌1例并文献复习

马强, 梁春立

同济大学附属东方医院甲状腺外科,上海 200120

收稿日期:2022-08-24 出版日期:2022-12-28 发布日期:2023-03-20
通讯作者: 梁春立,电子信箱：liang2006718@sina.com
作者简介:马强（1989—）,男,博士,主治医师,从事甲状腺乳腺肿瘤外科临床工作
基金资助:
国家自然科学基金青年项目（81902363）

Synchronous occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma： a case report and literature review

MA Qiang, LIANG Chunli

Department of Thyroid Surgery, East Hospital, Tongji University, Shanghai 200120, China

Received:2022-08-24 Online:2022-12-28 Published:2023-03-20

摘要/Abstract

摘要： 目的探讨甲状腺髓样癌合并乳头状癌患者的临床特征、病理特点、诊疗情况。方法回顾性分析1例甲状腺髓样癌合并乳头状癌患者的临床表现、检验检查及病理学结果,并复习相关文献。结果患者女性,56岁,因双侧甲状腺结节收入院,术前检测降钙素：>2000.0 pg/mL,CEA：132.0 ng/mL,pro-GPR：440.0 ng/mL,怀疑髓样癌可能;术中冰冻病理提示：左侧甲状腺乳头状癌,右侧髓样癌可能;于全麻下行甲状腺全切和双侧颈部中央组淋巴结清扫术,术后病理结果诊断：左侧甲状腺乳头状癌,右侧甲状腺髓样癌。结论甲状腺髓样癌合并乳头状癌临床上比较罕见,本文通过病例分析和文献复习,为该类病人的诊疗提供借鉴。

关键词: 甲状腺髓样癌, 甲状腺乳头状癌, 诊断, 治疗

Abstract: Objective To investigate the clinicopathological features, diagnosis, and treatment of medullary thyroid carcinoma （MTC） complicated with papillary thyroid carcinoma （PTC）. Methods A retrospective analysis was conducted of a case of MTC and PTC and related literature was reviewed. Results A female patient was admitted to the hospital due to bilateral thyroid nodules. Preoperative calcitonin： >2000.0 pg/mL, CEA： 132.0 ng/mL, pro-GPR： 440.0 ng/mL. Preoperative diagnosis： medullary carcinoma? Intraoperative frozen pathology suggested PTC on the left and MTC on the right. Total thyroidectomy with bilateral central lymph node dissection was performed. Postoperative pathological results revealed right MTC and left PTC. Conclusion Synchronous occurrence of MTC and PTC in a patient is rare. This case report and literature review provide references for the diagnosis and treatment of such patients.

Key words: Medullary thyroid carcinoma, Papillary thyroid carcinoma, Diagnosis, Treatment

中图分类号:

R736.1

马强, 梁春立. 甲状腺髓样癌合并乳头状癌1例并文献复习[J]. 外科研究与新技术, 2022, 11(4): 270-273.

MA Qiang, LIANG Chunli. Synchronous occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma： a case report and literature review[J]. Surgical Research and New Technique, 2022, 11(4): 270-273.

参考文献

[1] Nabhan F, Dedhia PH, Ringel MD.Thyroid cancer, recent advances in diagnosis and therapy[J]. Int J Cancer, 2021, 149(5): 984-992.
[2] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30.
[3] Kim M, Kim BH.Current guidelines for management of medullary thyroid carcinoma[J]. Endocrinol Metab (Seoul), 2021, 36(3): 514-524.
[4] Kim WG, Gong G, Kim EY, et al.Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental[J]. Clin Endocrinol (Oxf), 2010, 72(2): 256-263.
[5] Fibbi B, Pinzani P, Salvianti F, et al.Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature[J]. Endocr Pathol, 2014, 25(3): 324-331.
[6] Jaber T, Dadu R, Hu MI.Medullary thyroid carcinoma[J]. Curr Opin Endocrinol Diabetes Obes, 2021, 28(5): 540-546.
[7] Thomas CM, Asa SL, Ezzat S, et al.Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines[J]. Curr Oncol, 2019, 26(5): 338-344.
[8] Haugen BR, Alexander EK, Bible KC, et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133.
[9] Treglia G, Aktolun C, Chiti A, et al.The 2015 revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine[J]. Eur J Nucl Med Mol Imaging, 2016, 43(8): 1486-1490.
[10] Wells SA, Jr., Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6): 567-610.
[11] Maia AL, Siqueira DR, Kulcsar MA, et al.Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism[J]. Arq Bras Endocrinol Metabol, 2014, 58(7): 667-700.
[12] Hu MI, Waguespack SG, Dosiou C, et al.Afirma genomic sequencing classifier and xpression atlas molecular findings in consecutive bethesda III-VI thyroid nodules[J]. J Clin Endocrinol Metab, 2021, 106(8): 2198-2207.
[13] 沈雷, 曹慧敏, 李苑. 基于分子生物学的甲状腺癌诊疗进展[J]. 外科研究与新技术, 2015, 4(3): 196-200.
[14] 中华医学会内分泌学分会, 中华医学会外科学分会内分泌学组, 中国抗癌协会头颈肿瘤专业委员会, et al. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华内分泌代谢杂志, 2012, 28(10): 779-797.
[15] Li J, Chen Y, Wang X, et al.The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer[J]. Transl Cancer Res, 2021, 10(4): 1900-1906.
[16] Yamaguchi K, Katagiri H, Takahashi M, et al.ProGRP is a possible tumor marker for patients with Ewing sarcoma[J]. Biomed Res, 2015, 36(4): 273-277.
[17] Parra-Robert M, Orois A, Augé JM, et al.Utility of proGRP as a tumor marker in the medullary thyroid carcinoma[J]. Clin Chem Lab Med, 2017, 55(3): 441-446.
[18] Ma SH, Liu QJ, Zhang YC, et al.Alternative surgical strategies in patients with sporadic medullary thyroid carcinoma: Long-term follow-up[J]. Oncol Lett, 2011, 2(5): 975-980.
[19] Fan W, Xiao C, Wu F.Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma[J]. J Int Med Res, 2018, 46(5): 1982-1989.
[20] Machens A, Dralle H.Biomarker-based risk stratification for previously untreated medullary thyroid cancer[J]. J Clin Endocrinol Metab, 2010, 95(6): 2655-2663.
[21] Jayasinghe R, Basnayake O, Jayarajah U, et al.Management of medullary carcinoma of the thyroid: a review[J]. J Int Med Res, 2022, 50(7): 1-20.
[22] Pena I, Clayman GL, Grubbs EG, et al.Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer[J]. Head Neck, 2018, 40(1): 79-85.

甲状腺髓样癌合并乳头状癌1例并文献复习

Synchronous occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma： a case report and literature review

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	姚琼, 刘秀芬, 盛友华. 细胞DNA图像自动分析技术（DNA-ICM）在宫颈癌筛查中的应用价值[J]. 外科研究与新技术, 2022, 11(4): 238-241.
[2]	高峰, 杜海平. LVIS支架辅助治疗颈内动脉-后交通动脉（ICA-PcoA）动脉瘤的回顾性分析[J]. 外科研究与新技术, 2022, 11(2): 82-86.
[3]	王茜, 朱旭友, 张灏杨, 孙和国, 李佳, 高青云, 易祥华. 皮肤淋巴上皮瘤样癌1例及文献复习[J]. 外科研究与新技术, 2022, 11(1): 51-55.
[4]	张晓林, 金玲. 外耳道胆脂瘤36例临床分析[J]. 外科研究与新技术, 2021, 10(4): 273-276.
[5]	张珂, 沈洁, 胡丽华. 新型冠状病毒变异株对新型冠状病毒疾病诊治及防疫的影响分析[J]. 外科研究与新技术, 2021, 10(3): 203-208.
[6]	邹专, 和文宝, 李兵, 赵有光, 周海超, 杨云峰. 经皮复位空心螺钉固定治疗第五跖骨基底部撕脱性骨折[J]. 外科研究与新技术, 2021, 10(2): 97-100.
[7]	李晨光, 葛均波. 介入手术机器人系统在经皮冠状动脉介入治疗中的临床应用探讨[J]. 外科研究与新技术, 2021, 10(1): 1-3.
[8]	刘南斌, 许艳, 魏玉华, 刘中砚, 陈泉宁, 施宝民. 急性坏疽性胆囊炎39例诊疗分析[J]. 外科研究与新技术, 2021, 10(1): 37-41.
[9]	王春球, 李玉勤, 孟宪国, 陈应超, 钟雪瑜. 输尿管镜下气压弹道碎石术治疗输尿管中下段结石并发感染患者的临床效果[J]. 外科研究与新技术, 2020, 9(4): 234-236.
[10]	周彭玲, 周贤军, 白帆. 经阴道超声诊断剖宫产术后子宫切口憩室的临床效果[J]. 外科研究与新技术, 2020, 9(4): 267-270.
[11]	刘南斌, 吴刚, 卞崔冬. 12例TVT‐O术后并发吊带侵袭膀胱的诊疗分析[J]. 外科研究与新技术, 2020, 9(3): 154-157.
[12]	许艳, 刘南斌. 黄色肉芽肿性胆囊炎的临床困境[J]. 外科研究与新技术, 2020, 9(3): 197-200.
[13]	黄启豪. 自动痔疮套扎术联合地奥司明在混合痔临床治疗中的应用[J]. 外科研究与新技术, 2020, 9(1): 35-38.
[14]	谷丽, 于蕾, 张艺骞, 王新立. 马德龙病1例[J]. 外科研究与新技术, 2020, 9(1): 59-62.
[15]	朱旭友, 施娟红, 易祥华, 张子强, 郑少强, 张龙, 刘玉婷, 曾郁, 韩洪秀, 方霞. 经支气管冷冻肺活检诊断间质性肺疾病的价值分析[J]. 外科研究与新技术, 2019, 8(4): 248-252.